Reuters Now Stocks mixed; COVID-19 vaccine trials to restart
Wall Street closed narrowly mixed without an economic stimulus agreement in Washington. AstraZeneca and Johnson & Johnson both got the green light to restart U.S. clinical trials for the experimental COVID-19 vaccines. Conway G. Gittens has all the details.
Reuters Now Stocks mixed; COVID-19 vaccine trials to restart Trump keeps voter fraud claims, after DOJ rebuff Dems endorse bipartisan COVID bill as starting point CDC shortens quarantine period; warns against travel U.S. House passes bill targeting Chinese companies Biden will keep Trump's China tariffs... at first Taking S. Korea's grueling exam in COVID times U.N. says 2020 likely second hottest year Afghan govt, Taliban reach breakthrough deal Peru police seize nearly $6mln in counterfeit currency UK first in world to approve Pfizer vaccine U.S. bans cotton imports from China producers U.S. states to sue Facebook next week: sources Norwegian makes big proposals in bid to survive S&P 500 creeps to record high on stimulus hopes Boeing 737 MAX flies again with media onboard What pandemic? Holiday films stick with escapism Politicians urge people to buy Australian wine 48 NBA players have COVID-19 before season starts for-phone-only for-tablet-portrait-up for-tablet-landscape-up for-desktop-up for-wide-desktop-up